Edition:
United Kingdom

ESSA Pharma Inc (EPIX.OQ)

EPIX.OQ on NASDAQ Stock Exchange Capital Market

3.71USD
17 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.71
Open
$3.71
Day's High
$3.71
Day's Low
$3.71
Volume
23
Avg. Vol
2,262
52-wk High
$7.20
52-wk Low
$2.08

Latest Key Developments (Source: Significant Developments)

Essa Pharma Qtrly Loss Per Share $0.50
Tuesday, 14 Aug 2018 

Aug 14 (Reuters) - ESSA Pharma Inc ::ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS FINANCIAL RESULTS FOR FISCAL THIRD QUARTER ENDED JUNE 30, 2018.ESSA PHARMA INC - QTRLY LOSS PER COMMON SHARE $0.50.  Full Article

Essa Pharma Files For Offering Of About 113.9 Million Common Shares That May Be Offered For Resale By Selling Shareholders
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Essa Pharma Inc ::ESSA PHARMA INC FILES FOR OFFERING OF ABOUT 113.9 MILLION COMMON SHARES THAT MAY BE OFFERED FOR RESALE BY SELLING SHAREHOLDERS - SEC FILING.  Full Article

Essa Says Intends To Issue Up To 125 Mln Common Shares At $0.20 Per Share
Wednesday, 3 Jan 2018 

Jan 2 (Reuters) - Essa Pharma Inc ::ESSA ANNOUNCES FILING OF AMENDED AND RESTATED PROSPECTUS SUPPLEMENT AND AN UPDATE TO PREVIOUSLY ANNOUNCED EQUITY OFFERING.ESSA PHARMA - INTENDS TO ISSUE UP TO 125,000,000 COMMON SHARES AT A PRICE OF US$0.20 PER COMMON SHARE FOR AGGREGATE GROSS PROCEEDS OF UP TO US$25 MILLION.  Full Article

Essa Pharma Announces Pricing Of Previously Announced Equity Offering
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - Essa Pharma Inc ::ESSA PHARMA ANNOUNCES PRICING OF PREVIOUSLY ANNOUNCED EQUITY OFFERING.ESSA PHARMA INC - ‍ESSA INTENDS TO ISSUE COMMON SHARES IN CAPITAL OF COMPANY AT A PRICE OF US$0.20 PER COMMON SHARE.  Full Article

ESSA Pharma announces overnight marketed equity offering
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Essa Pharma Inc ::ESSA PHARMA ANNOUNCES OVERNIGHT MARKETED EQUITY OFFERING.ESSA PHARMA - TO USE NET PROCEEDS OF OFFERING PRIMARILY TO CONTINUE ONGOING PRECLINICAL DEVELOPMENT OF CO'S ANITEN COMPOUNDS.  Full Article

Essa Pharma Reports Qtrly Loss Per Share Of $0.07
Tuesday, 12 Dec 2017 

Dec 11 (Reuters) - ESSA Pharma Inc ::ESSA PHARMA ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL FOURTH QUARTER AND YEAR ENDED SEPTEMBER 30, 2017.QTRLY BASIC AND DILUTED LOSS PER COMMON SHARE $0.07‍​.‍CASH ON HAND AS AT SEPTEMBER 30, 2017 WAS $3.98 MILLION, WITH WORKING CAPITAL OF $1.28 MILLION​.  Full Article